Advertisement

Kolorektales Karzinom

  • Karsten Schulmann
  • Wolff Schmiegel
Part of the Molekulare Medizin book series (MOLMED)

Zusammenfassung

Kolorektale Karzinome (KRK) sind die häufigsten bösartigen Tumoren des Gastrointestinaltrakts und die zweithäufigste zum Tod führende Tumorerkrankung in Deutschland. In Deutschland verstarben 1997 29774 Patienten an den Folgen eines kolorektalen Karzinoms. Jährlich treten in Deutschland <55 000 Neuerkrankungen auf.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aaltonen LA, Peltomäki P, Mecklin JP et al. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645–1648PubMedGoogle Scholar
  2. Ahnen DJ, Feigl P, Quan G et al. (1998) Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res 58:1149–1158PubMedGoogle Scholar
  3. Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA (1998) Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study. J Natl Cancer Inst 90:675–684PubMedGoogle Scholar
  4. Askling J, Dickman PW, Karlen P et al. (2001) Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 357:262–266PubMedGoogle Scholar
  5. Behrens J, Jerchow BA, Würtele M et al. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599PubMedGoogle Scholar
  6. Benhattar J, Losi L, Chaubert P, Givel JC, Costa J (1993) Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 104:1044–1048PubMedGoogle Scholar
  7. Bodmer WF.., Bailey CJ, Bodmer J et al. (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614–616PubMedGoogle Scholar
  8. Boland CR, Sato J, Appelman H.D., Bresalier RS, Feinberg AP (1995) Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene lod during colorectal cancer progression. Nat Med 1:902–909PubMedGoogle Scholar
  9. Bomme L, Bardi G, Pan dis N, Fenger C, Kronborg O, Heim S (1998) Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer enet Cytogenet 106:66–71Google Scholar
  10. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49:4682–4689PubMedGoogle Scholar
  11. Bouzourene H, Gervaz P, Cerottini JP et al. (2000) p53 and Ki-ras as prognostic factors for Dukes’ stage B colorectal cancer. Eur J Cancer 36:1008–1015PubMedGoogle Scholar
  12. Brockman JA, Gupta RA, DuBois RN (1998) Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049–1055PubMedGoogle Scholar
  13. Buglioni S, D’Agnano I, Cosimelli M et al. (1999) Evaluation of multiple bio-pathological factors in colorectal adenocardnomas:independent prognostic role of p53 and bcl-2. Int J Cancer 84:545–552PubMedGoogle Scholar
  14. Burt RW (2000) Colon cancer screening. Gastroenterology 119:837–853PubMedGoogle Scholar
  15. Cahill DP, Lengauer C, Yu J et al. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392:300–303PubMedGoogle Scholar
  16. Carethers JM, Hawn MT, Greenson JK, Hitchcock CL, Boland CR (1998) Prognostic significance of allelic lost at chromosome 18q21 for stage 11 colorectal cancer. Gastroenterology 114:1188–1195PubMedGoogle Scholar
  17. Cerottini JP, Caplin S, Saraga E, Givel JC, Benhattar J (1998) The type of K-ras mutation determines pro gnosis in colorectal cancer. Am J Surg 175:198–202PubMedGoogle Scholar
  18. Chan GK, Schaar BT, Yen TJ (1998) Characterization of the kinetochore binding domain of CENP-E reveals interactions with the kinetochore proteins CENP-F and hBUBR1. J Cell Biol 143:49–63PubMedCentralPubMedGoogle Scholar
  19. Chang TH, Szabo E (2000) Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res 60:1129–1138PubMedGoogle Scholar
  20. Chen YQ, Hsieh JT, Yao F et al. (1999) Induction of apoptosis and G2/M ceH cyde arrest by DCC. Oncogene 18:2747–2754PubMedGoogle Scholar
  21. Cho KR, Oliner JD, Simons JWet al. (1994) The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19:525–531PubMedGoogle Scholar
  22. Cunningham JM, Christensen ER, Tester DJ et al. (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455–3460PubMedGoogle Scholar
  23. Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ (1994) The common molecular genetic alterations in Dukes’ Band C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 59:747–751PubMedGoogle Scholar
  24. Dong SM, Kim KM, Kim SY et al. (1998) Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 58:3787–3790PubMedGoogle Scholar
  25. Dube S, Heyen F, Jenieck M (1997) Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis.Dis Colon Rectum 40:35–41PubMedGoogle Scholar
  26. Duval A, Gayet J, Zhou X.P., Iacopetta B, Thomas G, Hamelin R (1999) Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 59:4213–4215PubMedGoogle Scholar
  27. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cydooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188PubMedGoogle Scholar
  28. Elsaleh H, Powell B, Soontrapornchai P et al. (2000) p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes’ C colon carcinoma. Oncology 58:52–59PubMedGoogle Scholar
  29. Eppert K, Scherer SW, Ozcelik H et al. (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543–552PubMedGoogle Scholar
  30. Esteller M, Avizienyte E, Corn PG et al. (2000) Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19:164–168PubMedGoogle Scholar
  31. Fante R, Di Gregorio C, Losi L, Roncucci L, Ponz DL (1996) Clinico-pathological correlation and prognostic significance of nudear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena. Ital J Gastroenterol Hepatol 28:205–210Google Scholar
  32. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767PubMedGoogle Scholar
  33. Fearon ER, Cho KR, Nigro JM et al. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56PubMedGoogle Scholar
  34. Finkelstein SD, Sayegh R, Bakker A, Swalsky P (1993) Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 128:526–531PubMedGoogle Scholar
  35. Fuchs CS, Giovannucci EL., Colditz GA, Hunter DJ, Speizer F.E., Willett WC (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331:1669–1674PubMedGoogle Scholar
  36. Ganten D, Ruckpaul K (Hrsg) (2001) Molekularmedizinische Grundlagen von hereditären Tumorerkrankungen.Springer, Berlin Heidelberg New YorkGoogle Scholar
  37. Giardiello FM, Hamilton SR, Krush AJ et al. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316PubMedGoogle Scholar
  38. Giatromanolaki A, Stathopoulos GP, Tsiobanou E et al. (1999) Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 86:1421–1430PubMedGoogle Scholar
  39. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC (1995) Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87:265–273PubMedGoogle Scholar
  40. Graeven U, Schmiegel W (2000) Das Kolonkarzinom. Konsensus der therapeutischen Strategien. Internist (Berl) 41:876–885Google Scholar
  41. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monodonal antibodies against cytokeratin and CC49.Correlation with long-term survival. Cancer 73:563–569PubMedGoogle Scholar
  42. Gruber SB, Entius MM, Petersen GM et al. (1998) Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 58:5267–5270PubMedGoogle Scholar
  43. Gryfe R, Kim H, Hsieh ET et al. (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69–77PubMedGoogle Scholar
  44. Guan RJ, Ford H.L., Fu Y, Li Y, Shaw LM, Pardee AB (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749–755PubMedGoogle Scholar
  45. Hahn SA, Schutte M, Hoque AT et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353PubMedGoogle Scholar
  46. Hamelin R, Laurent-Puig P, Olschwang S et al. (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42–48PubMedGoogle Scholar
  47. Harris JE, Ryan L, Hoover HC et al. (2000) Adjuvant active specific immunotherapy for stage 11 and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol 18:148–157PubMedGoogle Scholar
  48. He TC, Chan TA, Vogelstein B, Kinzier KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335–345PubMedCentralPubMedGoogle Scholar
  49. Heald RJ, Moran BJ, Ryall RD, Sexton R., MacFariane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133:894–899Google Scholar
  50. Hedrick L, Cho KR, Boyd J, Risinger J, Vogelstein B (1992) DCC: a tumor suppressor gene expressed on the cell surface. Cold Spring Harb Symp Quant Biol 57:345–351PubMedGoogle Scholar
  51. Heiss MM, Babie R, Allgayer H et al. (1995) Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J Clin Oncol 13:2084–2093PubMedGoogle Scholar
  52. Hemminki A, Markie D, Tomlinson I et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.Nature 391:184–187PubMedGoogle Scholar
  53. Hermanek P, Wiebelt H, Riedl S, Staimmer D, Hermanek P, Studiengruppe Kolorektales Karzinom (SGKRK) (1994) Langzeitergebnisse der chirurgischen Therapic des Coloncareinoms. Chirurg 65:287–297PubMedGoogle Scholar
  54. Hermanek P, Wiebelt H, Staimmer D, Riedl S (1995) Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 81:60–64PubMedGoogle Scholar
  55. Hohenberger W, Hermanek P, König HJ (2000) Kolon-, Rektum-und Analkanaltumoren. In: Hahn WG, Riemann JF, Demling L (Hrsg) Klinische Gastroenterologie, 3. Aufl. Thieme, Stuttgart New York, S 991–1024Google Scholar
  56. Houlston R, Bevan S, Williams A et al. (1998) Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet7:1907–1912PubMedGoogle Scholar
  57. Howe JR, Ringold JC, Summers RW, Mitros FA, Nishimura D.Y., Stone EM (1998) A gene for familial juvenile polyposis maps to chromosome 18q21.1. Am J Hum Genet 62:1129–1136PubMedCentralPubMedGoogle Scholar
  58. Huang J, Papadopoulos N, McKinley AJ et al. (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 93:9049–9054PubMedCentralPubMedGoogle Scholar
  59. Imai Y, Shiratori Y, Kato N, Inoue T, Omata M (1999) Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers. Jpn J Cancer Res 90:837–840PubMedGoogle Scholar
  60. Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065–2068PubMedGoogle Scholar
  61. Itoh F, Hinoda Y, Ohe M et al. (1993) Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer 53:260–263PubMedGoogle Scholar
  62. Jass JR, Sobin LH (1989) Histological typing of intestinal tumours.WHO International Histological Classification of Tumours, 2nd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  63. Jen J, Kim H, Piantadosi S et al. (1994a) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331:213–221PubMedGoogle Scholar
  64. Jen J, Powell SM, Papadopoulos N et al. (1994b) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523–5526PubMedGoogle Scholar
  65. Jenne DE, Reimann H, Nezu J et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43PubMedGoogle Scholar
  66. Kane MF, Loda M, Gaida GM et al. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor celllines. Cancer Res 57:808–811PubMedGoogle Scholar
  67. Kataoka M, Okabayashi T, Orita K (1995) Decreased expression of DCC mRNA in gastric and colorectal cancer. Surg Today 25:1001–1007PubMedGoogle Scholar
  68. Kato M, Ho Y, Kobayashi S, Isono K (1996) Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.Cancer 77:1729–1735PubMedGoogle Scholar
  69. Keino-Masu K, Masu M, Hinck L et al. (1996) Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 87:175–185PubMedGoogle Scholar
  70. Kern SE, Fearon ER, Tersmette KWet al. (1989) Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 261:3099–3103PubMedGoogle Scholar
  71. Khine K, Smith DR, Goh HS (1994) High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer 73:28–35PubMedGoogle Scholar
  72. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170PubMedGoogle Scholar
  73. Kinzler KW, Nilbert MC, Su LK et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665PubMedGoogle Scholar
  74. Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK (1995) The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10:1581–1586PubMedGoogle Scholar
  75. Knudson AGJ, Meadows AT, Nichols WW, Hili R. (1976) Chromosomal deletion and retinoblastoma. N Engl J Med 295:1120–1123PubMedGoogle Scholar
  76. Konishi M, Kikuchi-Yanoshita R, Tanaka K et al. (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111:307–317PubMedGoogle Scholar
  77. Korchynskyi O, Landstrom M, Stoika R et al. (1999) Expression of Smad proteins in human colorectal cancer. Int J Cancer 82:197–202PubMedGoogle Scholar
  78. Koyama M, Ito M, Nagai H, Emi M, Moriyama Y (1999) Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat Res 406:71–77PubMedGoogle Scholar
  79. Kune GA, Kune S, Vitetta L, Watson LF (1992) Smoking and colorectal cancer risk: data from the Melbourne Colorectal Cancer Study and brief review of literature. Int J Cancer 50:369–372PubMedGoogle Scholar
  80. Labayle D, Fischer D, Vielh P et al. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635–639PubMedGoogle Scholar
  81. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3:1487–1495PubMedGoogle Scholar
  82. Lanza G, Matteuzzi M, Gafa R et al. (1998) Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 79:390–395PubMedGoogle Scholar
  83. Launonen V, Avizienyte E, Loukola A et al. (2000) No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in leftsided colorectal carcinomas. Cancer Res 60:546–548PubMedGoogle Scholar
  84. Laurent-Puig P, Olschwang S, Delattre O et al. (1992) Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 102:1136–1141PubMedGoogle Scholar
  85. Lee JC, Wang ST, Lai MD, Lin YJ, Yang HB (1996) K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers. Anticancer Res 16:3839–3844PubMedGoogle Scholar
  86. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643–649PubMedGoogle Scholar
  87. Lev Z, Kislitsin D, Rennert G, Lerner A (2000) Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer. J Cell Bioehern [Suppl]34:35–39Google Scholar
  88. Lichtenstein P, Holm NY, Verkasalo PK et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85PubMedGoogle Scholar
  89. Liefers GJ, Cleton-Jansen AM, van de Velde CJ et al. (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223–228PubMedGoogle Scholar
  90. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685–689PubMedGoogle Scholar
  91. Livesey FJ (1999) Netrins and netrin receptors. Cell Mol Life Sci 56:62–68PubMedGoogle Scholar
  92. Lothe RA, Peltomäki P, Meling GI et al. (1993) Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53:5849–5852PubMedGoogle Scholar
  93. Lu SL, Kawabata M, Imamura T et al. (1998) HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nat Genet 19:17–18PubMedGoogle Scholar
  94. MacGrogan D, Pegram M, Slamon D, Bookstein R (1997) Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15:1111–1114PubMedGoogle Scholar
  95. Maitra A, Molberg K, Albores-Saavedra J, Lindberg G (2000) Loss of Dpc4 expression in colonie adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol 157:1105–1111PubMedCentralPubMedGoogle Scholar
  96. Markowitz S, Wang J, Myeroff L et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338PubMedGoogle Scholar
  97. Martinez-Lopez E, Abad A, Font A et al. (1998) Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114:1180–1187PubMedGoogle Scholar
  98. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395:801–804PubMedGoogle Scholar
  99. Minamoto T, Mai M, Ronai Z (2000) K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers-a review. Cancer Detect Prev 24:1–12PubMedGoogle Scholar
  100. Mirabelli-Primdahl L, Gryfe R, Kim H et al. (1999) Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59:3346–3351PubMedGoogle Scholar
  101. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al. (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020PubMedGoogle Scholar
  102. Miyaki M, Iijima T, Kimura J et al. (1999a) Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59:4506–4509PubMedGoogle Scholar
  103. Miyaki M, Iijima T, Konishi M et al. (1999b) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18:3098–3103PubMedGoogle Scholar
  104. Miyoshi Y, Nagase H, Ando H et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1:229–233PubMedGoogle Scholar
  105. Mulcahy HE, Skelly MM, Husain A, O’Donoghue DP (1996) Long-term outcome following curative surgery for malignant large bowel obstruction. Br J Surg 83:46–50PubMedGoogle Scholar
  106. Narayanan R, Lawlor KG, Schaapveld RQ et al. (1992) Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 7:553–561PubMedGoogle Scholar
  107. Nemunaitis J, Cox J, Meyer W, Courtney A, Mues G (1997) Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU). Am J Clin Oncol 20:527–529PubMedGoogle Scholar
  108. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. (1994) Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 73:2076–2082PubMedGoogle Scholar
  109. Nollau P, Moser C, Weinland G, Wagener C (1996) Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66:332–336PubMedGoogle Scholar
  110. Nordlinger B, Guiguet M, Vaillant JC et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.Cancer 77:1254–1262PubMedGoogle Scholar
  111. Nowell PC (1976) The clonal evolution of tumor cell populations.Science 194:23–28PubMedGoogle Scholar
  112. Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396–1407PubMedGoogle Scholar
  113. Ogunbiyi OA, Goodfellow PJ, Herfarth K et al. (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427–433PubMedGoogle Scholar
  114. Olschwang S, Hamelin R, Laurent-Puig P et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127PubMedCentralPubMedGoogle Scholar
  115. Pantel K, Knebel D von (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101PubMedGoogle Scholar
  116. Paradiso A, Simone G, Petroni S et al. (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567PubMedCentralPubMedGoogle Scholar
  117. Parsons R, Myeroff LL, Liu B et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550PubMedGoogle Scholar
  118. Pocard M, Bras-Goncalves R, Hamelin R, Northover J, Poupon MF (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res20:85–90PubMedGoogle Scholar
  119. Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:FI27–FI47Google Scholar
  120. Poller DN, Baxter KJ, Shepherd NA (1997) p53 and Rbl protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75:87–93PubMedCentralPubMedGoogle Scholar
  121. Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167PubMedCentralPubMedGoogle Scholar
  122. Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932PubMedGoogle Scholar
  123. Powell SM, Zilz N, Beazer-Barday Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237PubMedGoogle Scholar
  124. Pricolo VE, Finkelstein SD, Wu TT et al. (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41–46PubMedGoogle Scholar
  125. Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132:371–374PubMedGoogle Scholar
  126. Resta N, Simone C, Mareni C et al. (1998) STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res 58:4799–4801PubMedGoogle Scholar
  127. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer.Dis Colon Rectum 41:755–760PubMedGoogle Scholar
  128. Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204PubMedGoogle Scholar
  129. Nollau P, Moser C, Weinland G, Wagener C (1996) Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66:332–336PubMedGoogle Scholar
  130. Nordlinger B, Guiguet M, Vaillant JC et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.Cancer 77:1254–1262PubMedGoogle Scholar
  131. Nowell PC (1976) The clonal evolution of tumor cell populations.Science 194:23–28PubMedGoogle Scholar
  132. Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396–1407PubMedGoogle Scholar
  133. Ogunbiyi OA, Goodfellow PJ, Herfarth K et al. (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427–433PubMedGoogle Scholar
  134. Olschwang S, Hamelin R, Laurent-Puig P et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127PubMedCentralPubMedGoogle Scholar
  135. Pantel K, Knebel D von (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101PubMedGoogle Scholar
  136. Paradiso A, Simone G, Petroni S et al. (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567PubMedCentralPubMedGoogle Scholar
  137. Parsons R, Myeroff LL, Liu B et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550PubMedGoogle Scholar
  138. Pocard M, Bras-Goncalves R, Hamelin R, Northover J, Poupon MF (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res20:85–90PubMedGoogle Scholar
  139. Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:FI27–FI47Google Scholar
  140. Poller DN, Baxter KJ, Shepherd N.A (1997) p53 and Rbl protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75:87–93PubMedCentralPubMedGoogle Scholar
  141. Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167PubMedCentralPubMedGoogle Scholar
  142. Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932PubMedGoogle Scholar
  143. Powell SM, Zilz N, Beazer-Barday Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237PubMedGoogle Scholar
  144. Pricolo VE, Finkelstein SD, Wu TT et al. (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41–46PubMedGoogle Scholar
  145. Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132:371–374PubMedGoogle Scholar
  146. Resta N, Simone C, Mareni C et al. (1998) STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res 58:4799–4801PubMedGoogle Scholar
  147. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer.Dis Colon Rectum 41:755–760PubMedGoogle Scholar
  148. Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204PubMedGoogle Scholar
  149. Nollau P, Moser C, Weinland G, Wagener C (1996) Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66:332–336PubMedGoogle Scholar
  150. Nordlinger B, Guiguet M, Vaillant JC et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.Cancer 77:1254–1262PubMedGoogle Scholar
  151. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23–28PubMedGoogle Scholar
  152. Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396–1407PubMedGoogle Scholar
  153. Ogunbiyi OA, Goodfellow PJ, Herfarth K et al. (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427–433PubMedGoogle Scholar
  154. Olschwang S, Hamelin R, Laurent-Puig P et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127PubMedCentralPubMedGoogle Scholar
  155. Pantel K, Knebel D von (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101PubMedGoogle Scholar
  156. Paradiso A, Simone G, Petroni S et al. (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567PubMedCentralPubMedGoogle Scholar
  157. Parsons R, Myeroff LL, Liu B et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550PubMedGoogle Scholar
  158. Pocard M, Bras-Goncalves R, Hamelin R, Northover J, Poupon MF (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res20:85–90PubMedGoogle Scholar
  159. Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:FI27–FI47Google Scholar
  160. Poller DN, Baxter KJ, Shepherd N.A (1997) p53 and Rbl protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75:87–93PubMedCentralPubMedGoogle Scholar
  161. Porter GA, Soskolne CL, Yakimets WW, Newman.S.C (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167PubMedCentralPubMedGoogle Scholar
  162. Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932PubMedGoogle Scholar
  163. Powell SM, Zilz N, Beazer-Barday Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237PubMedGoogle Scholar
  164. Pricolo VE, Finkelstein SD, Wu TT et al. (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41–46PubMedGoogle Scholar
  165. Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132:371–374PubMedGoogle Scholar
  166. Resta N, Simone C, Mareni C et al. (1998) STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res 58:4799–4801PubMedGoogle Scholar
  167. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer.Dis Colon Rectum 41:755–760PubMedGoogle Scholar
  168. Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204PubMedGoogle Scholar
  169. Riethmüller G, Holz E, Schlimok G et al. (1998) Monoclonal antibody therapy for resected Dukes’ C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 16:1788–1794PubMedGoogle Scholar
  170. Riggins GJ, Kinzier KW, Vogelstein B, Thiagalingam S (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57:2578–2580PubMedGoogle Scholar
  171. Roberts BT, Farr KA, Hoyt MA (1994) The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol Cell Biol 14:8282–8291PubMedCentralPubMedGoogle Scholar
  172. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023–1026PubMedGoogle Scholar
  173. Saito M, Yamaguchi A, Goi T et al. (1999) Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis. Oncology 56:134–141PubMedGoogle Scholar
  174. Sarraf P, Mueller E, Jones D et al. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 4:1046–1052PubMedGoogle Scholar
  175. Sarraf P, Mueller E, Smith WM et al. (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 3:799–804PubMedGoogle Scholar
  176. Schmiegel W, Adler G, Frühmorgen P et al. (2000) Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung-Vorsorge bei Risikopatienten-Endoskopische Diagnostik, Therapic und Nachsorge von Polypen und Karzinomen. Z Gastroenterol 38:49–75PubMedGoogle Scholar
  177. Schumpelick V, Willis S, Kasperk R (2000) Moderne Operationsverfahren des Rektumkarzinoms: Sind adjuvante Maßnahmen notwendig? Dtsch Arztebl 97:A1138Google Scholar
  178. Schwarte-Waldhoff I, Klein S, Blass-Kampmann S et al. (1999) DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18:3152–3158PubMedGoogle Scholar
  179. Schwarte-Waldhoff I, Volpert OV, Bouck NP et al. (2000) Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 97:9624–9629PubMedCentralPubMedGoogle Scholar
  180. Shibata D, Reale MA, Lavin P et al. (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335:1727–1732PubMedGoogle Scholar
  181. Shiff SJ, Rigas B (1997) Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113:1992–1998PubMedGoogle Scholar
  182. Shitoh K, Furukawa T, Kojima M et al. (2001) Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal careinomas with microsatellite instability. Genes Chromosomes Cancer 30:32–37PubMedGoogle Scholar
  183. Sidransky D, Tokino T, Hamilton SR et al. (1992) Identification of ras on co gene mutations in the stool of patients with curable colorectal tumors. Science 256:102–105PubMedGoogle Scholar
  184. Smith AJ, Stern HS, Penner M et al. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54:5527–5530PubMedGoogle Scholar
  185. Smith DR, Ji C.Y., Goh HS (1996) Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 74:216–223PubMedCentralPubMedGoogle Scholar
  186. Smith-Ravin J, England J, Talbot IC, Bodmer W (1995) Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 36:81–86PubMedCentralPubMedGoogle Scholar
  187. Soussi T (2000) p53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60:1777–1788PubMedGoogle Scholar
  188. Sparks AB, Morin PJ, Vogelstein B, Kinzier KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130–1134PubMedGoogle Scholar
  189. Starzynska T, Bromley M, Marlicz K, Roberts SA, Ucinski M, Stern PL (1997) Accumulation of p53 in relation to longterm prognosis in colorectal carcinoma. Eur J Gastroenterol Hepatol 9:183–186PubMedGoogle Scholar
  190. Steinbach G, Lynch PM, Phillips RK et al. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952PubMedGoogle Scholar
  191. Takagi Y, Kohmura H, Futamura M et al. (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111:1369–1372PubMedGoogle Scholar
  192. Takagi Y, Koumura H, Futamura M et al. (1998) Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 78:1152–1155PubMedCentralPubMedGoogle Scholar
  193. Takahashi Y, Tucker SL, Kitadai Y et al. (1997) Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132:541–546PubMedGoogle Scholar
  194. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645–656PubMedGoogle Scholar
  195. Takanishi D.MJ, Angriman I, Yaremko ML, Montag A, Westbrook CA, Michelassi F (1995) Chromosome 17p allelic loss in colorectal carcinoma. Clinical significance. Arch Surg 130:585–588PubMedGoogle Scholar
  196. Takenoshita S, Tani M, Mogi A et al. (1998) Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis 19:803–807PubMedGoogle Scholar
  197. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90:1529–1536PubMedGoogle Scholar
  198. Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T, Miyaki M (1991) Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349:340–342PubMedGoogle Scholar
  199. Taylor SS, McKeon F (1997) Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727–735PubMedGoogle Scholar
  200. Taylor SS, Ha E, McKeon F (1998) The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase. J Cell Biol 142:1–11PubMedCentralPubMedGoogle Scholar
  201. Thiagalingam S, Lengauer C, Leach FS et al. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343–346PubMedGoogle Scholar
  202. Thibodeau SN, French AJ, Cunningham J.M et al. (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58:1713–1718PubMedGoogle Scholar
  203. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C (1998) A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317:559–565PubMedCentralPubMedGoogle Scholar
  204. Trojan J, Brieger A, Raedle J, Esteller M, Zeuzem S (2000) 5’-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut 47:272–276PubMedCentralPubMedGoogle Scholar
  205. Troungos C, Valavanis C, Kapranos N, Kittas C (1997) K-ras mutation in Greek patients with poorly and moderately differentiated tumours of the lower intestinal tract. Anticancer Res 17:1399–1404PubMedGoogle Scholar
  206. Van Beizen N, Dinjens W.N., Diesveld MP et al. (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77:85–92Google Scholar
  207. Veigl ML, Kasturi L, Olechnowicz J et al. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 95:8698-8702Google Scholar
  208. Vermorken JB, Claessen AM, Tinteren H van et al. (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353:345–350PubMedGoogle Scholar
  209. Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532PubMedGoogle Scholar
  210. Winawer SJ, Zauber AG, Gerdes H et al. (1996) Risk of colorectal cancer in the families of patients with adenomatous polyps.National Polyp Study Workgroup. N Engl J Med 334:82–87PubMedGoogle Scholar
  211. Wittekind C, Wagner C (1997) TNM-Klassifikation maligner Tumoren, 5. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  212. World Cancer Research Fund (1996) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DCGoogle Scholar
  213. Wu GD (2000) A nuclear receptor to prevent colon cancer. N Engl J Med 342:651–653PubMedGoogle Scholar
  214. Zeng Z.S., Sarkis AS, Zhang ZF et al. (1994) p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 12:2043–2050PubMedGoogle Scholar
  215. Zhou S, Buckhaults P, Zawel L et al. (1998a) Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95:2412–2416PubMedCentralPubMedGoogle Scholar
  216. Zhou H, Kuang J, Zhong L et al. (1998b) Tumour amplified kinase STK15/BTAK in duces centrosome amplification, aneuploidy and transformation. Nat Genet 20:189–193PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Karsten Schulmann
  • Wolff Schmiegel

There are no affiliations available

Personalised recommendations